Jason Bock is the founder and CEO of the Cell Therapy Manufacturing Center, or CTMC, a joint venture between National Resilience and MD Anderson Cancer Center that hopes to serve as an engine for advancing cell therapy therapeutics for cancer patients. Formed just over a year ago, CTMC has expanded its footprint and already worked on a handful of innovative treatments. Jason shares a bit on how this progress has gone so far and why he’s bullish on Houston being a hub for the relatively young field of cell therapy manufacturing.